Neil Conlon (@neil_conlon) 's Twitter Profile
Neil Conlon

@neil_conlon

@DCU cancer researcher, science/sports/all-round nerd (he/him)

ID: 100834292

calendar_today31-12-2009 19:56:50

2,2K Tweet

620 Takipçi

1,1K Takip Edilen

ProfJohnCrown (@profjohncrown) 's Twitter Profile Photo

Attention!!! Delighted to host Prof Richard O’Reilly from Memorial Sloan Kettering Cancer Center )Memorial Sloan-Kettering Cancer Center NY) at our Inaugural 2024-25 CCRT Medical Oncology Seminar Series. Please re post

Attention!!! Delighted to host Prof Richard O’Reilly from <a href="/MSKCancerCenter/">Memorial Sloan Kettering Cancer Center</a> )Memorial Sloan-Kettering Cancer Center NY) at our Inaugural 2024-25 <a href="/CCRTIreland/">CCRT</a> Medical Oncology Seminar Series. Please re post
Neil Conlon (@neil_conlon) 's Twitter Profile Photo

Thanks go to Gerry Hanna for organising this research retreat. It’s brilliant to have so many experts in radiation oncology across the island in one room. Thankful for the opportunity to present some of our work.

Neil Conlon (@neil_conlon) 's Twitter Profile Photo

frontiersin.org/research-topic… The deadline is extended for submission to the Frontiers Genetics special issue on “3D in Vitro Models - A New Era in Cancer Research”

Gerry Hanna (@gerryhanna) 's Twitter Profile Photo

Huge thanks to colleagues across Ireland who came together for our Radiation Oncology translation research retreat 🙏 👉 Such energy positivity expertise and creativity as we form our ITROG constortoum 🙌 Irish Research Radiation Oncology Group Irish Radiation Research Society Irish Cancer Society CancerTrialsIreland 🌈 NCCP HSE Ireland

Huge thanks to colleagues across Ireland who came together for our Radiation Oncology translation research retreat 🙏

👉 Such energy positivity expertise and creativity as we form our ITROG constortoum 🙌 

<a href="/IRROGTrials/">Irish Research Radiation Oncology Group</a> <a href="/irrsoc/">Irish Radiation Research Society</a>  <a href="/IrishCancerSoc/">Irish Cancer Society</a> <a href="/cancertrials_ie/">CancerTrialsIreland 🌈</a> <a href="/hseNCCP/">NCCP</a> <a href="/HSELive/">HSE Ireland</a>
Dublin City University (@dcu) 's Twitter Profile Photo

Meet #IUA3MT finalist Niall Ashfield representing DCU. Niall is on a mission to improve treatments for HER2-positive breast cancer by studying the combined effects of two approved drugs and developing models to understand treatment resistance. More info: iua.ie/3minutethesis

Neil Conlon (@neil_conlon) 's Twitter Profile Photo

Thank you to the Croatian Association for Cancer Research for inviting me to speak at HDIR-7 in Zagreb. Inspired by the impactful work to understand cancer from the molecular to the population level.

Thank you to the Croatian Association for Cancer Research for inviting me to speak at HDIR-7 in Zagreb. Inspired by the impactful work to understand cancer from the molecular to the population level.
IPSC (@ipsc48) 's Twitter Profile Photo

Amazing shot at the FAI Cup Final between Derry City and Drogheda United this evening. 🇵🇸 #FreePalestine #SolidarityIsAVerb Image: Stephen McCarthy

Amazing shot at the FAI Cup Final between Derry City and Drogheda United this evening. 🇵🇸 #FreePalestine #SolidarityIsAVerb 
Image: Stephen McCarthy
Neil Conlon (@neil_conlon) 's Twitter Profile Photo

Trading pipettes for paintbrushes and lab coats for aprons—our Christmas lab outing was all about pottery, painting, and pizza

Trading pipettes for paintbrushes and lab coats for aprons—our Christmas lab outing was all about pottery, painting, and pizza
Paolo Tarantino (@ptarantinomd) 's Twitter Profile Photo

A new ADC is now available to treat the most common subtype of breast cancer. Datopotamab deruxtecan (Dato-DXd), which targets Trop2 and delivers DXd, is approved for pretreated patients with HR+/HER2- MBC, after outperforming chemo in the #TB01 trial. fda.gov/drugs/resource…

A new ADC is now available to treat the most common subtype of breast cancer.

Datopotamab deruxtecan (Dato-DXd), which targets Trop2 and delivers DXd, is approved for pretreated patients with HR+/HER2- MBC, after outperforming chemo in the #TB01 trial.

fda.gov/drugs/resource…
Neil Conlon (@neil_conlon) 's Twitter Profile Photo

So proud of Luna Stockmann! Grateful to Breakthrough Cancer Research and Research Ireland for funding this important work on ovarian cancer treatments. Thanks to the PPI advocates and OvaCare for helping Luna refine her presentation.

Larissa Katharina Bless (@blessklarissa) 's Twitter Profile Photo

Honoured to be invited to present my PhD Project "Enhancing Targeted Therapies for Triple Negative Breast Cancer" as a Lay-Poster in the Patrick G Johnston Session (5th of March 2025) at the Annual IACR Conference News IACR

Honoured to be invited to present my PhD Project "Enhancing Targeted Therapies for Triple Negative Breast Cancer" as a Lay-Poster in the Patrick G Johnston Session (5th of March 2025) at the Annual IACR Conference <a href="/News_IACR/">News IACR</a>
Neil Conlon (@neil_conlon) 's Twitter Profile Photo

Check out Luna Stockmann’s amazing explanation of her research, why her research question is so important, and what she’s doing to help uncover kinder cancer treatments.

ProfJohnCrown (@profjohncrown) 's Twitter Profile Photo

Dr Slamon the man whose research led to Herceptin. His work saves tens of thousands of women’s lives per year. Giving an open lecture Herbert Park Hotel & Park Residence Dublin Weds Sept 24 600pm. Free registration [email protected]. Sponsored by CCRT Dublin City University